Login / Signup

High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab.

Edoardo ConticiniFederico FranchiDavid BennettSerafina ValenteMaria A MazzeiElena BargagliLuca VolterraniSabino ScollettaBruno Frediani
Published in: Annals of the rheumatic diseases (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • rheumatoid arthritis
  • high dose
  • juvenile idiopathic arthritis
  • combination therapy
  • low dose
  • replacement therapy